ProMIS Neurosciences (PMN) Live Share Price, Invest From India

ProMIS Neurosciences Stock Performance

as on September 12, 2026 at 2:16 pm IST

Day's Low
Day's High
$13.01
Day's Price Range
$13.94
$13.56
4.06%
Downside
2.80%
Upside
52 Week's Low
52 Week's High
$6.27
52-Week Price Range
$27.40
$13.56
53.76%
Downside
102.06%
Upside

ProMIS Neurosciences share price movements today

Previous Close: $13.40
Open: $13.30
Volume: 132.6K
Market Cap: $128.8M
Day's Low - High: $13.01 - $13.94
52 Week Low - High: $6.27 - $27.40

ProMIS Neurosciences Historical Returns

1 Month Return: -2.41 %
3 Month Return: + 40.83 %
1 Year Return: + 43.65 %
3 Year Return: -69.02 %
5 Year Return: 0 %

ProMIS Neurosciences Stock Fundamentals & Key Indicators

Check ProMIS Neurosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$128.8M

EPS (TTM)

-7.358

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-13.3M

Revenue (TTM)

7.6K

Profit Margin

0.00%

Return On Equity TTM

-172.30%

ProMIS Neurosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ProMIS Neurosciences with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
ProMIS Neurosciences	BUY	$128.8M	NA	NA	0.00%	NA
Revolution Medicines	BUY	$44.6B	614.61%	NA	0.00%	NA
Vertex Pharmaceuticals	BUY	$138.4B	181.2%	30.54	86.04%	NA
Moderna	BUY	$56.0B	-69.82%	-16.99	-12.57%	NA
Regeneron	BUY	$85.2B	24.16%	19.28	84.86%	45.660000000000004%

Stock Returns calculator for ProMIS Neurosciences Stock including INR - Dollar returns

The ProMIS Neurosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

ProMIS Neurosciences investment value today

Current value as on today

₹1,47,030

Returns

₹47,030

(+47.03%)

Returns from ProMIS Neurosciences Stock

₹35,600 (+35.6%)

Dollar Impact

₹11,430 (+11.43%)

Analyst Recommendation on ProMIS Neurosciences Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for ProMIS Neurosciences. Average target price of $43.92

ProMIS Neurosciences Share Price Target

Get share price movements and forecasts by analysts on ProMIS Neurosciences.

What analysts predicted

69.13%UPSIDE

Target Price

$43.92

Current Price

$13.56

Analyzed by

6 Analysts

Target

$43.92

ProMIS Neurosciences target price $43.92, a slight upside of 69.13% compared to current price of $13.56. According to 6 analysts rating.

Indian Investors' Interest in ProMIS Neurosciences Stock

Search interest for ProMIS Neurosciences Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 15, 2026 to September 14, 2026

Change:-57% versus previous 30 day period

ProMIS Neurosciences Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	0	-	-	-	-	-	-	-	-	-
Gross Profit	0	-	-	-4	-	-	-	-9	-	-
Operating Income	-3	-2	-4	-6	-7	-10	-11	-10	-8	-12
EBITDA	-3	-2	9	-5	-7	-10	-11	-10	-8	-11
Interest Expense	0	-	-	76	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-3	-2	9	0	-7	-10	-11	-10	-8	-11
Income Tax Expense	0	-	-	-	-	-	-	-	-	-
Net Income	-3	-2	9	0	-7	-10	-11	-10	-8	-11
Net Profit Margin	-57929.69%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

ProMIS Neurosciences Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	0	0	0	0	-	-	-
Gross Profit	0	0	0	-3	-2	-4	0	-10	-	-33
Operating Income	-2	-6	-7	-12	-5	-10	-23,379	-18	-16	-40
EBITDA	-2	-4	-7	-7	-5	-9	-17,780	-17	2	-39
Interest Expense	0	0	-	-	-	0	282	0	0	-
Depreciation	-	-	0	0	0	0	0	0	-	-
Income Before Tax	-2	-6	-7	-7	-5	-12	-18,062	-17	2	-39
Income Tax Expense	0	0	0	-	-	0	-5	0	-	-
Net Income	-1	-3	-5	-5	-4	-9	-13,295	-17	2	-39
Net Profit Margin	-128395.30%	-48380.52%	-2140457.07%	-615329.37%	-361814.19%	-71819.34%	-221930566.31%	0.00%	0.00%	0.00%

ProMIS Neurosciences Quarterly Cash Flow

All numbers in Millions USD

	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-2	9	0	-7	-10	-11	-39,690	-8	-11
Operating Cash Flow	-1	-6	-8	-4	-3	-10	-9	-12	-10
Investing Cash Flow	-	-	0	-	-	-	0	-	-
Financing Cash Flow	0	27	0	-	-	21	0	70	-
Change in Cash	-1	20	-8	-4	-3	10	-9	57	-10

ProMIS Neurosciences Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-4	-7	-7	-5	-9	-24	-13	2	-39
Operating Cash Flow	-4	-6	-6	-4	-9	-22	-10	-27	-28
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	5	6	5	3	25	8	17	27	20
Change in Cash	0	0	0	0	16	-14	6	0	-7

Mutual Funds that own ProMIS Neurosciences Stock

Check out the Mutual Funds with significant holdings in ProMIS Neurosciences.

Funds	Holdings	Shares Held
Fidelity Concord Street Trust	0.003835%	344

Global Institutional Holdings in ProMIS Neurosciences

Funds	Holdings
Michael Rockefeller	4.93%
Dimensional	0%

Insights on ProMIS Neurosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, PMN stock has moved up by 7.6%
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 512.4% return, outperforming this stock by 489.1%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 27.6% return, outperforming this stock by 101.8%

About ProMIS Neurosciences

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS, which enables drug discovery through a combination of protein biology, physics, and supercomputing. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers for treating Alzheimer's disease; PMN267 for the treatment of amyotrophic lateral sclerosis; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils for treating multiple system atrophy. The company also develops PNM440, an alpha-synuclein vaccine for treating multiple synucleinopathies; and PMN311, an amyloid-beta vaccine for the treatment of Alzheimer's. In addition, it is developing therapies for frontotemporal lobar degeneration, Huntington's disease, progressive supranuclear palsy, corticobasal degeneration, and schizophrenia. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. is headquartered in Toronto, Canada.

Organisation	ProMIS Neurosciences
Headquarters	1920 Yonge Street, Toronto, ON, Canada, M4S 3E2
Industry	Biotechnology
CEO	Mr. Neil K. Warma M.B.A.
E-voting on shares	Click here to vote

Key Management of ProMIS Neurosciences

Name	Title
Dr. Johanne Kaplan Ph.D.	Chief Development Officer
Dr. Larry Douglas Altstiel M.D., Ph.D.	Chief Medical Officer
Mr. Daniel E. Geffken M.B.A.	Chief Financial Officer
Dr. David Wishart Ph.D.	Chief Physics Officer
Mr. Dennis Chen Ph.D.	Head of Manufacturing & Senior Consultant
Mr. Eugene W. Williams	Co-Founder & Chairman
Mr. Neil K. Warma M.B.A.	CEO, President, Compliance Officer & Director
Dr. Neil R. Cashman M.D.	Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director

FAQs

What is ProMIS Neurosciences share price today?

ProMIS Neurosciences share price today is $13.56 as on September 12, 2026 at 8:46 am IST at the close of the market. ProMIS Neurosciences share today touched a day high of $13.94 and a low of $13.01.

What is the 52 week high and 52 week low for ProMIS Neurosciences share?

ProMIS Neurosciences share touched a 52 week high of $27.40 on March 5, 2026 and a 52 week low of $6.27 on November 28, 2025. ProMIS Neurosciences stock price today i.e. September 12, 2026 at 8:46 am IST is closed at $13.56,which is 50.51% down from its 52 week high and 116.27% up from its 52 week low.

What is ProMIS Neurosciences's market capitalisation today?

ProMIS Neurosciences market capitalisation is $0.00T as on September 12, 2026 at 8:46 am IST.

How to invest in ProMIS Neurosciences Stock (PMN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for ProMIS Neurosciences on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ProMIS Neurosciences Shares that will get you 0.1106 shares as per ProMIS Neurosciences share price of $13.56 per share as on September 12, 2026 at 8:46 am IST.

What is the minimum amount required to buy ProMIS Neurosciences Stock (PMN) from India?

Indian investors can start investing in ProMIS Neurosciences (PMN) shares with as little as ₹95.55 or $1 (as of September 14, 2026 at 7:47 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹955.50 in ProMIS Neurosciences stock (as per the Rupee-Dollar exchange rate as on September 14, 2026 at 7:47 am IST). Based on ProMIS Neurosciences share’s latest price of $13.56 as on September 12, 2026 at 8:46 am IST, you will get 0.7375 shares of ProMIS Neurosciences. Learn more about fractional shares .